We use cookies to improve your experience on this website. Read More Allow Cookies

BIOMARIN OPENS NEW DUBLIN OFFICES FOR GROWTH ACROSS EUROPE, MIDDLE EAST AND AFRICA

04 October, 2019

BioMarin Pharmaceutical Inc, a global leader in therapies for rare genetic diseases, opened its new offices in Dublin to provide a hub for the Company’s growing operations across EU, the Middle East and Africa (EUMEA).

The new offices in Earlsfort Terrace further strengthens BioMarin’s presence in Ireland. A €38 million expansion of BioMarin’s manufacturing facility in Cork was announced last year and is also currently in progress.

BioMarin is a global biopharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. 

The new offices were officially opened by AnTánaiste, Minister for Foreign Affairs & Trade, Simon Coveney at an event that brought together members of BioMarin’s Global Executive team including President of Global Manufacturing, Dr Robert Baffi, employees, members of the medical and life science communities, public representatives and patient representative groups including Avril Daly, Chairperson of Rare Diseases Ireland. 

For more information, click HERE.